{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01375",
      "entity_text" : "TNF-alpha",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q01105",
      "entity_text" : "set",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "A first set of data have shown that DNAM-1 gene invalidation through the use of DNAM-1 deficient mice or the treatment of mice with DNAM-1 neutralizing antibodies prevented the development of dermal fibrosis in the bleomycin mouse model by reducing the infiltration of lesional skin by inflammatory cells and preventing the release of proinflammatory cytokines (TNF-alpha and IL-6).",
  "reading_complete" : "2020-08-04T12:15:51Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:14:49Z",
  "trigger" : "prevented",
  "evidence" : [ "set of data have shown that DNAM-1 gene invalidation through the use of DNAM-1 deficient mice or the treatment of mice with DNAM-1 neutralizing antibodies prevented the development of dermal fibrosis in the bleomycin mouse model by reducing the infiltration of lesional skin by inflammatory cells and preventing the release of proinflammatory cytokines (TNF-alpha" ],
  "pmc_id" : "6305435",
  "score" : 0
}